PEOPLE - Changes at SynCardia Systems:
This article was originally published in Clinica
Executive Summary
SynCardia Systems' plans to launch the CardioWest Total Artificial Heart in the US have gone a step further with the appointment of Michael Quinn, chairman and CEO of Cardiogenesis, as vice-chairman of the board. SynCardia chairman and CEO Dr Marvin Slepian said the move addresses the "need for leadership and a profound understanding of the challenges of commercialising advanced cardiovascular therapies". The appointment is part of the company's "necessary restructuring ... as it transitions from a research organisation to a commercially viable company", added the co-founder of the Tucson, Arizona-based company. Cardiogenesis, of Foothill Ranch, California, makes the Holmium: YAG laser and related accessories for transmyocardial revascularisation (TMR) therapy and percutaneous myocardial channelling.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.